OPCH Option Care Health, Inc. Common Stock

XNAS 31.29 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

OPCH $31.29 —
Key stats
$31.29
52-Week Range
$18.01 – $36.80
YTD
-2.95%
IV Rank (30D)
5.03
Straddle Price
$0.88
P/C Vol Ratio
2.02
Market Cap
$4.7B
Open
$31.28
Day Range
$31.24 – $31.30
Volume
2,512,949
Prev Close
$31.23
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.96%
Beta vs SPY0.79
Cost of Equity (CAPM)8.89% (VRP-adj)
WACC8.25%
Volatility Risk Premium+7.2pp (IV − HV30)
Effective Tax Rate26.6%
Rev. Growth (YoY, DCF input)+0.5%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.01 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$0.3B
Return on Equity (TTM)16.6%
Book / Price25.3%
Gross Margin (TTM)19.1%
FCF Margin (TTM)5.3%
Debt / Equity0.91
Quality Score1/6 — cyclical/struggling (5y DCF)
Market-Implied Growth+4.6% (reverse-DCF on current price)
SMA 50$25.86 (Market Anchor value)
SMA 20 / Bollinger Mid$29.07
Bollinger Width / SMA20172.1% (drives anchor stability)
Net Debt$1.0B
Market Cap$5B
Peers used for multiples: CAI, ELV, HCA, INSM, MOH, PSNL, TEVA, UNH
60-Day Conviction
34%
20-Day Fair Value
≈ by Nov 25, 2026
$32.25
α +3.1% rank 48%
conviction
98%
40-Day Fair Value
≈ by Dec 24, 2026
$32.10
α +2.6% rank 54%
conviction
78%
60-Day Fair Value
≈ by Jan 22, 2027
$31.59
α +1.0% rank 46%
conviction
34%
MethodImplied PriceWeightDetail
DCF $25.07 44%
DDM (Gordon) n/a 0%
Peer P/E $35.25 20% median 26.6× · 5 peers
Peer EV/EBITDA $33.29 20% median 15.4× · 6 peers
Peer P/B $46.83 4% median 5.9× · 7 peers
Peer P/S $70.85 13% median 2.0× · 8 peers
Market Anchor (SMA50) $25.86 0% stability 0% (BB-width)
Options Expected (B-L 30d) $31.75 0% 6 strikes · skew +0.57
As of 2026-10-27 · updated
About
Industry (SIC)
SERVICES-HOME HEALTH CARE SERVICES (8082) · industry map
Exchange
XNAS
Market Cap
$4.7B
Employees
8,266
List Date
1996-08-15
CIK
0001014739
Next Earnings
2026-10-29 (Pre-Market)
EPS Forecast
$0.44 (5 est.)
Headquarters
Bannockburn, IL
Homepage
https://www.optioncarehealth.com

Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan17.56%-17.86%-2.14%-8.95%36.21%5.46%5.05%
Feb-1.39%8.44%5.11%1.83%9.17%-6.21%2.82%
Mar-10.27%12.71%1.53%4.42%2.92%-14.81%-0.58%
Apr4.49%4.04%1.32%-8.84%-7.55%-23.25%-4.96%
May-4.58%6.75%-15.59%-0.53%1.59%4.19%-1.36%
Jun17.83%-5.92%17.17%-7.26%1.95%2.49%4.38%
Jul-5.39%17.77%4.19%8.60%-8.14%9.38%4.40%
Aug31.32%-8.56%3.26%4.06%1.49%-1.05%5.09%
Sep-12.39%2.68%-6.42%-3.31%-2.39%-4.86%-4.45%
Oct10.11%-7.15%-16.58%-23.58%-4.44%38.57%*-0.51%
Nov-9.35%-0.73%3.77%-1.29%17.71%--2.02%
Dec16.13%-2.34%11.37%-3.81%2.97%--4.86%
Total54.19%4.41%1.58%-35.45%54.45%-1.46%12.95%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $29.49
SMA 50: $26.02
SMA 200: $26.36
Current: $31.29
EMA 12: $30.67
EMA 26: $28.91
MACD: 1.7626 | Signal: -0.0829
BULLISH
ADX (14): 51.89
STRONG TREND
+DI: 52.42
−DI: 10.19

Momentum Oscillators

RSI (14): 82.30
OVERBOUGHT
Stoch %K: 66.22
Stoch %D: 75.56
Williams %R: -24.32

Volume & Volatility

BB Upper: $36.22
BB Lower: $22.76
NEUTRAL
OBV: 126,771,742
Vol SMA 20: 7,319,719
Vol ROC: -49.88%
ATR: $0.45
True Range: $0.07
HV 20: 100.5%
HV 30: 84.0%
HV 60: 61.2%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-29T00:00:00 – 2026-10-27T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary Overall Assessment: NEUTRAL (Confidence Level: 6/10) Key Drivers: Recent positive news headlines, improving technical signals Primary Risks: Options market volatility, potential earnings misses Investment Thesis: OPCH's recent price action is driven by a mix of positive fundamental and technical factors. The stock's low volatility and bullish options activity support the thesis. Recent News Sentiment Impact: Positive headlines (Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026) have contributed to the stock's upward momentum.

Technical Analysis Trend Direction:

  • Short-term: Uptrend (1-4 weeks)
  • Medium-term: Consolidation (1-3 months)
  • Long-term: Uptrend (3-12 months)

Support/Resistance Levels:

  • SMA 20: $23.73
  • SMA 50: $22.54

Momentum Signals:

  • RSI interpretation: Neutral (59.39), not overbought or oversold
  • MACD signal: Bullish momentum, above signal line
  • Bollinger Bands position: Squeeze, with price approaching the upper band

Volume Analysis:

  • Volume SMA 20: 2165292.27
  • On-Balance Volume (OBV): 25914017.81
Generated
News
All OPCH news →
Earnings History
15 of 18 under expected move
Avg Expected Move
10.98%
Avg Actual Move
7.39%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-05-06 Pre-Market 13.28% 4.50% 0.34x Within
2022-02-23 Pre-Market 5.39% 5.30% 0.98x Within
2022-07-27 Pre-Market 11.30% 2.63% 0.23x Within
2022-10-27 Pre-Market 15.29% 12.06% 0.79x Within
2023-05-03 Pre-Market 12.01% 1.74% 0.14x Within
2023-07-27 Pre-Market 8.01% 4.38% 0.55x Within
2023-10-25 Pre-Market 9.37% 15.49% 1.65x Exceeded
2024-02-22 Pre-Market 11.48% 2.43% 0.21x Within
2024-04-23 Pre-Market 8.55% 0.59% 0.07x Within
2024-07-31 Pre-Market 9.09% 5.30% 0.58x Within
2024-10-30 Pre-Market 8.03% 22.79% 2.84x Exceeded
2025-02-26 Pre-Market 12.41% 1.59% 0.13x Within
2025-04-29 Pre-Market 11.30% 6.92% 0.61x Within
2025-07-30 Pre-Market 9.13% 1.69% 0.19x Within
2025-10-30 Pre-Market 13.52% 8.60% 0.64x Within
2026-02-24 Pre-Market 10.53% 6.30% 0.60x Within
2026-04-30 Pre-Market 13.96% 24.34% 1.74x Exceeded
2026-07-29 Pre-Market 14.90% 6.45% 0.43x Within

Earnings calendar: this week’s reports with expected vs actual moves →

OPCH Options Activity & IV Rank

OPCH IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 13.1%
7-DTE IV: —
Expected Move: $0.88
7-DTE Move: $0.88
Days to Exp: 24 (2026-11-20)

Options Flow

Call Volume: 64
Put Volume: 129
P/C Volume: 2.016
BEARISH
Call OI: 1,225
Put OI: 583
P/C OI: 0.476
Total OI: 1,808

ATM Options Pricing

ATM Call: $0.07
ATM Put: $0.80
Call %: 0.2%
Put %: 2.6%

Chain Summary

Chain Volume: 408
Chain OI: 14,260
Last Updated: 10/27/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
HIGH γ vs HISTORY

Estimated net dealer gamma is at the 100th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
100%
vs own history
GEX tilt
+0.88
OI-weighted, today
Vanna tilt
+0.98
δ-sensitivity to IV
Charm tilt
-0.97
δ-decay vs time
Vanna tilt +0.98: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.97: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 11 ATM contracts, 10k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Oct 26 · No data
30 DTE / 10d —
— pts EXTREME
as of Oct 26 · ATM 13.0% / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)5.0LowOct 27
Straddle Price (30 DTE)$0.88Oct 27
Beta Analysis

Risk Metrics

Beta: 0.0741
Alpha: 24.32%
Correlation: 0.0178
R-Squared: 0.0%
Stock Volatility: 52.8%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own OPCH
5 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Millennium Management Hedge fund
Izzy Englander
$54.9M
0.04%
#571 of 3716+59.6%13F
Point72 Hedge fund
Steve Cohen
$37.8M
0.06%
#403 of 1945+219.9%13F
Citadel Hedge fund
Ken Griffin
$34.3M
0.02%
#866 of 6285-53.8%13F
Bridgewater Associates Hedge fund
Ray Dalio
$2.3M
0.01%
#676 of 997new13F
Rockefeller Capital Management Family office
Rockefeller family
$187K
0.00%
#2635 of 4729-2.6%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

OPCH Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 159,536,250 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

391 filers175,155,805 shares$3.86B value109.79% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Group Inc Custodian 16,647,553 $530.39M 13.73% 10.44% 2025-12-31
2 BlackRock, Inc. Custodian 22,104,863 $463.54M 12.00% 13.86% 2026-06-30
3 Wellington Management Group LLP Custodian 11,782,384 $247.08M 6.40% 7.39% 2026-06-30
4 Vanguard Portfolio Management LLC 8,274,458 $173.52M 4.49% 5.19% 2026-06-30
5 FULLER & THALER ASSET MANAGEMENT, INC. 7,450,698 $156.24M 4.05% 4.67% 2026-06-30
6 Vanguard Capital Management LLC 7,063,747 $148.13M 3.84% 4.43% 2026-06-30
7 Durable Capital Partners LP 6,163,722 $129.25M 3.35% 3.86% 2026-06-30
8 State Street Corp 6,139,898 $128.75M 3.33% 3.85% 2026-06-30
9 Arrowstreet Capital, Limited Partnership 5,980,270 $125.41M 3.25% 3.75% 2026-06-30
10 Dimensional Fund Advisors LP Custodian 5,449,294 $114.28M 2.96% 3.42% 2026-06-30
11 Geode Capital Management, LLC Custodian 4,467,797 $93.71M 2.43% 2.80% 2026-06-30
12 Millennium Management LLC Custodian 2,618,869 $54.92M 1.42% 1.64% 2026-06-30
13 Charles Schwab Investment Management, Inc. 2,464,334 $51.68M 1.34% 1.54% 2026-06-30
14 Bank of America Corp Custodian 2,266,839 $47.54M 1.23% 1.42% 2026-06-30
15 Morgan Stanley Custodian 2,240,837 $46.99M 1.22% 1.40% 2026-06-30
16 Van Berkom & Associates Inc. 2,185,884 $45.84M 1.19% 1.37% 2026-06-30
17 Goldman Sachs Group Inc Custodian 2,165,092 $45.40M 1.18% 1.36% 2026-06-30
18 Sumitomo Mitsui Trust Group, Inc. 2,132,614 $44.72M 1.16% 1.34% 2026-06-30
19 Northern Trust Corp Custodian 1,961,486 $41.13M 1.06% 1.23% 2026-06-30
20 Boston Partners 1,952,275 $41.00M 1.06% 1.22% 2026-06-30
21 Nuveen, LLC Custodian 1,938,948 $40.66M 1.05% 1.22% 2026-06-30
22 Swedbank AB 1,891,500 $39.66M 1.03% 1.19% 2026-06-30
23 FMR LLC Custodian 1,819,131 $38.15M 0.99% 1.14% 2026-06-30
24 Point72 Asset Management, L.P. 1,800,244 $37.75M 0.98% 1.13% 2026-06-30
25 Norges Bank 1,673,104 $35.08M 0.91% 1.05% 2026-06-30
13 filers$39.34M notional
# Filer Notional Value % of Total Period
1 Citadel Advisors LLC Custodian $21.94M 55.76% 2026-06-30
2 Cinctive Capital Management LP $3.06M 7.78% 2026-06-30
3 Walleye Trading LLC $2.42M 6.14% 2026-06-30
4 Jane Street Group, LLC Custodian $2.15M 5.46% 2026-06-30
5 Crawford Fund Management, LLC $2.08M 5.28% 2026-06-30
6 Susquehanna International Group, LLP Custodian $2.05M 5.21% 2026-06-30
7 IMC-Chicago, LLC Custodian $2.02M 5.14% 2026-06-30
8 GROUP ONE TRADING LLC Custodian $1.88M 4.77% 2026-06-30
9 TUDOR INVESTMENT CORP ET AL $448.76K 1.14% 2026-06-30
10 Tidal Investments LLC $436.18K 1.11% 2026-06-30
11 Walleye Capital LLC $366.98K 0.93% 2026-06-30
12 Simplex Trading, LLC Custodian $297.77K 0.76% 2026-06-30
13 Wolverine Trading, LLC Custodian $206.55K 0.53% 2025-09-30
6 filers$1.71M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $1.29M 75.52% 2026-06-30
2 IMC-Chicago, LLC Custodian $205.51K 12.00% 2026-06-30
3 Walleye Capital LLC $148.89K 8.69% 2026-06-30
4 GROUP ONE TRADING LLC Custodian $44.04K 2.57% 2026-06-30
5 Simplex Trading, LLC Custodian $16.78K 0.98% 2026-06-30
6 Walleye Trading LLC $4.19K 0.24% 2026-06-30

OPCH Insider Trading (Form 4)

Latest: 2026-07-08
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-07-08 Prateek Bhatia EVP Sp Sales & Solutions Award (A) +39,795 — EDGAR
2026-05-22 Eric Brandt Director Award (A) +11,640 $22.23 $58.8K EDGAR
2026-05-22 Norman L. Wright Director Award (A) +8,997 — EDGAR
2026-05-22 Barbara W. Bodem Director Award (A) +8,997 — EDGAR
2026-05-22 Timothy P Sullivan Director Award (A) +13,833 $22.23 $107.5K EDGAR
2026-05-22 R Carter Pate Director Award (A) +8,997 — EDGAR
2026-05-22 Harry M Jansen Kraemer Jr Director Award (A) +21,076 $22.23 $268.5K EDGAR
2026-05-22 Natasha Deckmann Director Award (A) +9,841 $22.23 $18.8K EDGAR
2026-05-22 Elizabeth D Bierbower Director Award (A) +8,997 — EDGAR
2026-05-21 Collin Smyser GC & Corporate Secretary Mixed +452 $20.86 -$7.5K EDGAR
2026-05-07 Timothy P Sullivan Director Buy (P) +24,154 $20.69 $499.7K EDGAR
2026-05-05 Harry M Jansen Kraemer Jr Director Buy (P) +36,610 $21.41 $783.8K EDGAR
2026-05-04 John Charles Rademacher Chief Executive Officer Buy (P) +12,500 $21.18 $264.7K EDGAR
2026-05-04 Meenal Sethna Chief Financial Officer Buy (P) +16,225 $20.16 $327.1K EDGAR
2026-04-24 Femi Adewunmi Chief Medical Officer Tax (F) −1,396 $28.38 -$39.6K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

OPCH Insider Holdings

20 insiders · @ $31.29
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 John Charles Rademacher Chief Executive Officer 695,152 $21.75M $428.9K 18 2026-05-04
2 Harry M Jansen Kraemer Jr Director 458,997 $14.36M $8.50M 16 2026-05-22
3 Michael H. Shapiro Chief Financial Officer 311,933 $9.76M -$677.7K 14 2025-02-26
4 Luke Whitworth Chief Operating Officer 169,589 $5.31M $0 13 2026-02-26
5 David W Golding Director 116,525 $3.65M $27.6K 8 2025-08-21
6 Meenal Sethna Chief Financial Officer 98,337 $3.08M $327.1K 3 2026-05-04
7 Timothy P Sullivan Director 87,216 $2.73M -$1.86B 21 2026-05-22
8 Collin Smyser GC & Corporate Secretary 77,512 $2.43M $86.7K 15 2026-05-21
9 Christopher L. Grashoff Chief Growth Officer 44,092 $1.38M $0 11 2026-02-26
10 Michael Bavaro Chief Human Resources Officer 33,249 $1.04M -$1.67M 17 2026-03-03
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

OPCH Board & Officers

As of SEC filings through Jul 8, 2026

Directors 11

Officers 8

Changes in the last 10 years (99)
Jul 6, 2026Prateek Bhatia became EVP Sp Sales & Solutions
May 5, 2026The company announced the departure of Christopher L. Grashoff as Chief Growth Officer in an SEC filing
Oct 1, 2025Meenal Sethna became Chief Financial Officer
Sep 3, 2024The company announced the departure of John Arlotta from the board in an SEC filing
Aug 1, 2024Nicole Maggio became Chief Accounting Officer
May 15, 2024Eric Brandt became a director
Apr 22, 2024Femi Adewunmi became Chief Medical Officer
Jan 2, 2024Norman L. Wright became a director
Jan 2, 2024Barbara W. Bodem became a director
Dec 22, 2023The company announced the departure of Nitin Sahney from the board in an SEC filing
Dec 11, 2023The company announced the departure of Richard Denness as Chief Commercial Officer in an SEC filing
Dec 6, 2023Christopher L. Grashoff became Chief Growth Officer
Mar 3, 2023Walgreens Boots Alliance, Inc. reported in an SEC filing no longer being a 10% owner
Mar 3, 2023WBA US 1 Co. reported in an SEC filing no longer being a 10% owner
Mar 3, 2023WBA Investments, Inc. reported in an SEC filing no longer being a 10% owner
Mar 3, 2023OCH US Holding LLC reported in an SEC filing no longer being a 10% owner
Mar 3, 2023Hc Group Holdings I, LLC reported in an SEC filing no longer being a director
Mar 3, 2023Hc Group Holdings I, LLC reported in an SEC filing no longer being a 10% owner
Feb 24, 2023Collin Smyser listed as GC & Corporate Secretary (previously Gen. Counsel & Corp. Secy.) in SEC filings
Jan 16, 2023Michael Bavaro became Chief Human Resources Officer
Not reported recently (24)
  • Michael H. Shapiro · Last reported as Chief Financial Officer in an SEC filing dated Feb 26, 2025
  • Aaron Friedman · Last reported as a director in an SEC filing dated May 24, 2022
  • Anita M. Allemand · Last reported as a director in an SEC filing dated May 24, 2022
  • Mark Edmund Vainisi · Last reported as a director in an SEC filing dated May 18, 2022
  • Seema Kumbhat · Last reported as Chief Medical Officer in an SEC filing dated Feb 22, 2022
  • Clifford E Berman · Last reported as Senior Vice President, General Counsel and Corporate Secretary. in an SEC filing dated Jul 13, 2021
  • Robert R Kampstra · Last reported as Chief Accounting Officer in an SEC filing dated Jul 13, 2021
  • Alan Troy Nielsen · Last reported as a director in an SEC filing dated May 13, 2020
  • Christopher Frederick Hartman · Last reported as Chief Growth Officer in an SEC filing dated Aug 7, 2019
  • Michael Goldstein · Last reported as a director in an SEC filing dated Jun 5, 2019
  • Michael G Bronfein · Last reported as a director in an SEC filing dated Jun 5, 2019
  • Daniel E Greenleaf · Last reported as Chief Executive Officer in an SEC filing dated May 20, 2019
  • Stephen Deitsch · Last reported as Chief Financial Officer in an SEC filing dated May 20, 2019
  • Kathryn Stalmack · Last reported as General Counsel in an SEC filing dated Apr 18, 2019
  • Jody Kepler · Last reported as Chief Compliance Officer in an SEC filing dated Apr 11, 2019
  • John McMahon · Last reported as Chief Accounting Officer in an SEC filing dated Oct 31, 2018
  • Leslie McIntosh · Last reported as Chief Human Resources Officer in an SEC filing dated Aug 3, 2018
  • Alex Schott · Last reported as Senior Vice President in an SEC filing dated May 7, 2018
  • Gerald Anthony Lopez · Last reported as Chief Accounting Officer in an SEC filing dated Dec 1, 2017
  • Tricia Nguyen · Last reported as a director in an SEC filing dated May 4, 2017
  • Dave Evans · Last reported as SVP, Chief Operating Officer in an SEC filing dated Mar 17, 2017
  • Jeffrey M Kreger · Last reported as Chief Financial Officer in an SEC filing dated Mar 17, 2017
  • C. Britt Jeffcoat · Last reported as VP, Chief Accounting Officer in an SEC filing dated Mar 17, 2017
  • Steven Neumann · Last reported as a director in an SEC filing dated Jan 30, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

OPCH Proposed Insider Sales (Form 144)

Latest: 2026-02-27
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-02-27 Michael L Bavaro Officer 6,000 $198.0K 2026-02-27 Merrill Lynch — EDGAR
2026-02-26 Pate R Carter Director 30,287 $965.9K 2026-02-26 Fidelity Brokerage Services LLC — EDGAR
2025-02-28 Bavaro Michael Officer 30,996 $1.03M 2025-02-28 Merrill Lynch — EDGAR
2024-08-22 SHAPIRO MICHAEL H. Officer 23,217 $743.0K 2024-08-22 Merrill Lynch — EDGAR
2024-08-21 SULLIVAN TIMOTHY P Director 47,249 $1.46M 2024-08-22 Merrill Lynch — EDGAR
2024-08-21 BETTEN ELIZABETH QUADROS Director 47,531 $1.52M 2024-08-21 Merrill Lynch — EDGAR
2024-08-15 Bavaro Michael Officer 5,765 $184.5K 2024-08-15 Merrill Lynch 10b5-1 EDGAR
2024-02-28 Bavaro Michael Officer 1,984 $63.5K 2024-02-28 Merrill Lynch — EDGAR
2023-06-08 Walgreens Boots Alliance, Inc. Affiliate 10,771,926 $331.56M 2023-06-08 Morgan Stanley & Co. LLC — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-05-22
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-05-22 0001014739-26-000017 EDGAR
2026-05-12 0001104659-26-058979 EDGAR
2026-05-05 0001014739-26-000014 EDGAR
2026-04-30 0001104659-26-052099 EDGAR
2026-04-02 0001104659-26-039171 EDGAR
2026-02-24 0001014739-26-000005 EDGAR
2026-01-12 0001104659-26-002887 EDGAR
2025-10-30 0001014739-25-000043 EDGAR
2025-09-25 0001104659-25-093337 EDGAR
2025-08-20 0001104659-25-080912 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-24 0001014739-26-000008 EDGAR
2025-02-26 0001014739-25-000012 EDGAR
2024-02-22 0001014739-24-000009 EDGAR
2023-02-23 0001014739-23-000009 EDGAR
2022-02-23 0001014739-22-000009 EDGAR
2021-03-11 0001014739-21-000011 EDGAR
2020-03-05 0001014739-20-000013 EDGAR
2019-03-15 0001014739-19-000012 EDGAR
2018-03-26 0001628280-18-003541 EDGAR
2017-03-07 0001628280-17-002304 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-04-30 0001014739-26-000011 EDGAR
2025-10-30 0001014739-25-000046 EDGAR
2025-07-30 0001014739-25-000037 EDGAR
2025-04-29 0001014739-25-000022 EDGAR
2024-10-30 0001014739-24-000052 EDGAR
2024-07-31 0001014739-24-000035 EDGAR
2024-04-23 0001014739-24-000022 EDGAR
2023-10-25 0001014739-23-000042 EDGAR
2023-07-27 0001014739-23-000034 EDGAR
2023-05-04 0001014739-23-000019 EDGAR
ETF Holders
131 ETFs hold OPCH
25 shown · $970.88M total exposure · 0.17% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 IJH iShares Core S&P Mid-Cap ETF iShares (BlackRock) 0.14% $167.7M $122.8B 2026-10-26
2 IWM iShares Russell 2000 ETF iShares (BlackRock) 0.17% $125.3M $75.5B 2026-10-26
3 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $107.5M — 2026-09-30
4 VB Vanguard Morningstar Small-Cap ETF Vanguard 0.04% $75.7M — 2026-09-30
5 DFAT Dimensional US Targeted Value ETF Dimensional 0.21% $63.8M — 2026-10-26
6 DFAS Dimensional US Small Cap ETF Dimensional 0.13% $46.0M — 2026-10-26
7 FESM Fidelity Enhanced Small Cap Core ETF Fidelity 0.68% $45.3M $6.7B 2026-10-26
8 VXF Vanguard Extended Market ETF Vanguard 0.04% $37.9M — 2026-09-30
9 IWO iShares Russell 2000 Growth ETF iShares (BlackRock) 0.28% $37.9M $14.0B 2026-10-26
10 MDY State Street® SPDR® S&P MIDCAP 400® ETF Trust SPDR (State Street) 0.14% $35.1M $25.8B 2026-10-26
11 IJK iShares S&P Mid-Cap 400 Growth ETF iShares (BlackRock) 0.27% $28.2M $10.4B 2026-10-26
12 SPMD State Street® SPDR® Portfolio S&P 400™ Mid Cap ETF SPDR (State Street) 0.14% $25.1M $18.5B 2026-10-26
13 VBR Vanguard Morningstar Small-Cap Value ETF Vanguard 0.04% $24.7M — 2026-09-30
14 VBK Vanguard Morningstar Small-Cap Growth ETF Vanguard 0.05% $21.1M — 2026-09-30
15 VTWO Vanguard Russell 2000 ETF Vanguard 0.12% $20.9M — 2026-09-30
16 SCHA Schwab U.S. Small-Cap ETF Nport 0.07% $15.9M — 2026-05-31
17 DFMC Dimensional US Micro Cap ETF Dimensional 0.20% $15.5M — 2026-10-26
18 DFAC Dimensional US Core Equity 2 ETF Dimensional 0.02% $14.9M — 2026-10-26
19 VHT Vanguard Health Care ETF Vanguard 0.05% $10.0M — 2026-09-30
20 FNDA Schwab Fundamental U.S. Small Company ETF Nport 0.11% $9.6M — 2026-05-31
21 TSME Thrivent Small-Mid Cap Equity ETF Nport 0.91% $9.5M — 2026-06-30
22 SCHM Schwab U.S. Mid-Cap ETF Nport 0.06% $9.0M — 2026-05-31
23 IWN iShares Russell 2000 Value ETF iShares (BlackRock) 0.06% $8.7M $14.0B 2026-10-26
24 IHF iShares U.S. Healthcare Providers ETF iShares (BlackRock) 0.57% $8.0M $1.4B 2026-10-26
25 MDYG State Street® SPDR® S&P 400™ Mid Cap Growth ETF SPDR (State Street) 0.27% $7.6M $2.8B 2026-10-26
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
23.70
TTM Diluted EPS
$1.32
TTM Revenue
$5.69B
TTM Net Income
$209.58M
TTM Op. Cash Flow
$346.81M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30$1.44B$53.91M$0.35$183.59M
Q1 '262026-03-31$1.35B$45.34M$0.29$-12.11M
Q4 '252025-12-31$1.47B$58.50M$0.36$35.89M
Q3 '252025-09-30$1.44B$51.82M$0.32$139.44M
Q2 '252025-06-30$1.42B$50.52M$0.31$90.33M
Q1 '252025-03-31$1.33B$46.74M$0.28$-7.21M
Q4 '242024-12-31$1.35B$60.13M$0.36$36.12M
Q3 '242024-09-30$1.28B$53.86M$0.31$160.40M
Q2 '242024-06-30$1.23B$53.04M$0.30$195.66M
Q1 '242024-03-31$1.15B$44.79M$0.26$-68.78M
Q4 '232023-12-31$1.12B$57.18M$0.32$50.97M
Q3 '232023-09-30$1.09B$56.30M$0.31$61.04M
Q2 2026 • period ending 2026-06-30 • filed 2026-07-29
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
23.70
P/B
3.96
P/S
0.88
EV/EBITDA
14.69
EV/Sales
1.05
ROE
16.6%
ROA
6.2%
Div Yield
0.00%
FCF Yield
6.95%
Debt/Equity
0.91
Current Ratio
—
Market Cap
$4.99B
as of 2026-10-27
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
8.56M
SI % of Float
5.81%
Days to Cover
3.47
Short Vol Ratio
32.5%
Free Float
147.28M
Float %
98.3%
Short interest 2026-09-30 • Short volume 2026-10-27 • Float 2026-08-07